Cargando…
On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases
BACKGROUND: Abnormal cardiac uptake of (123)I-metaiodobenzylguanidine ((123)I-MIBG) is a diagnostic marker of Lewy body diseases (LBDs), e.g., Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Planar imaging is generally used to assess cardiac sympathetic dysfunction in (123)I-MIBG scint...
Autores principales: | Odagiri, Hayato, Baba, Toru, Nishio, Yoshiyuki, Iizuka, Osamu, Matsuda, Minoru, Inoue, Kentaro, Kikuchi, Akio, Hasegawa, Takafumi, Aoki, Masashi, Takeda, Atsushi, Taki, Yasuyuki, Mori, Etsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824520/ https://www.ncbi.nlm.nih.gov/pubmed/27055151 http://dx.doi.org/10.1371/journal.pone.0152746 |
Ejemplares similares
-
Logopenic aphasia due to Lewy body disease dramatically improved with donepezil
por: Kakinuma, Kazuo, et al.
Publicado: (2020) -
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
por: Shimizu, Soichiro, et al.
Publicado: (2015) -
Diagnosis of dementia with Lewy bodies: diagnostic performance of combined (123)I-IMP brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy
por: Sakamoto, Fumi, et al.
Publicado: (2013) -
Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes
por: Shin, Dong Hoon, et al.
Publicado: (2006) -
(123)I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
por: Kitamura, Yoshiyuki, et al.
Publicado: (2021)